--- title: "Diamondback's $16B Buyback and Equinox's M&A Push: Behind the Scenes of US Niche Sectors" type: "News" locale: "en" url: "https://longbridge.com/en/news/295518449.md" description: "Energy and mining firms are flexing their financial muscles. I'm told Diamondback and Equinox are accelerating buybacks and mergers after record Q2 output. Meanwhile, EV infrastructure and biotech players are rapidly restructuring to survive a tightening cash environment." datetime: "2026-08-11T10:12:53.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295518449.md) - [en](https://longbridge.com/en/news/295518449.md) - [zh-HK](https://longbridge.com/zh-HK/news/295518449.md) --- # Diamondback's $16B Buyback and Equinox's M&A Push: Behind the Scenes of US Niche Sectors The pace of capital consolidation in niche US sectors is accelerating faster than anyone anticipated earlier this year. I'm told that following a string of record-breaking production numbers in Q2 2026, major traditional energy and mining companies are using their massive free cash flow to reshape the competitive landscape through aggressive buybacks and acquisitions. On the flip side, smaller tech, EV infrastructure, and biotech firms are desperately maneuvering to clean up their balance sheets and maintain compliance. ### Diamondback Energy (FANG.US) The momentum behind this oil and gas heavyweight is staggering. I'm told that after Q2 2026 revenue surged 51.2% to a massive **USD 5.56B**, executives felt confident enough to double the company's share repurchase authorization to **USD 16B**. With production crossing the 1 million barrels of oil equivalent per day threshold for the very first time, this level of capital return is sending an unmistakably bullish signal to Wall Street despite broader commodity market volatility. ### Equinox Gold (EQX.US) Another resource giant making significant expansion moves is Equinox Gold. Fresh off completing its strategic business combination with Orla Mining in July 2026, the company has officially cemented its status as a premier North American gold producer. According to people familiar with the matter, internal projections for a combined annual output of 1.1 million ounces are incredibly optimistic. It's why the board just greenlit a **USD 436M** Phase 2 expansion for the Valentine mine and aggressively hiked its quarterly dividend by 50%. ### Blink Charging (BLNK.US) In stark contrast to the cash-rich energy players, Blink Charging is undergoing one of its most significant profitability overhauls to date. I've learned that despite lowering its full-year 2026 revenue guidance to between USD 83M and USD 90M, management is pivoting hard toward its higher-margin service segment. That division now accounts for 53% of total revenue, which helped narrow the Q2 net loss to **USD 6M**. After offloading its non-core Envoy Technologies unit, the company's singular focus right now is achieving adjusted EBITDA breakeven by the end of the year. ### Humacyte (HUMA.US) The margin for error in the biotech space continues to shrink. Humacyte reported a Q1 2026 net loss of USD 0.09 per share, which technically beat estimates, but revenue came in at a paltry **USD 495K**—missing consensus by a wide margin. I'm told the firm is making clinical progress with its bioengineered human tissue implants, but managing its cash runway remains an existential priority until it can reverse its multi-million dollar annual deficits. ### Also - **Ebang International (EBON.US)**: Beyond its core Bitcoin mining rig business, I'm told the blockchain company is quietly diversifying. It recently acquired industrial land in Inner Mongolia for a new amorphous and nanocrystalline materials project. - **Oncolytics Biotech (ONCY.US)**: The company received a Nasdaq warning letter over its recent stock performance. However, sources note it successfully locked down US patent protection for its flagship immunotherapy drug pelareorep until 2044, buying critical time for commercialization. - **EHang Holdings (EH.US)**: The autonomous aerial vehicle maker has been trading sideways recently. Investors are waiting for more concrete international orders and certification milestones before making their next move. - **Ridgetech (RDGT.US)**: Formerly China Jo-Jo Drugstores, the healthcare distributor reported FY2026 revenue of **USD 132.2M**. I'm told it is currently seeking regulatory approval for capital changes to overhaul its equity structure. - **Echostar Corporation (ECHX.US)**: The satellite communications firm continues to keep a low profile as it navigates intense broadband market competition and ongoing internal restructuring efforts. - **JPMorgan Ultra-Short Income ETF (JPST.US)**: This actively managed ETF remains a massive safe haven for institutional capital. With over **USD 40.5B** in AUM and a 30-day SEC yield of 4.13% as of mid-2026, it is still the go-to vehicle for investors demanding low principal volatility. _This article does not constitute investment advice._ ### Related Stocks - [FANG.US](https://longbridge.com/en/quote/FANG.US.md) - [EQX.US](https://longbridge.com/en/quote/EQX.US.md) - [BLNK.US](https://longbridge.com/en/quote/BLNK.US.md) - [HUMA.US](https://longbridge.com/en/quote/HUMA.US.md) - [EBON.US](https://longbridge.com/en/quote/EBON.US.md) - [ONCY.US](https://longbridge.com/en/quote/ONCY.US.md) - [EH.US](https://longbridge.com/en/quote/EH.US.md) - [RDGT.US](https://longbridge.com/en/quote/RDGT.US.md) ## Related News & Research - [Ebang International GAAP EPS of -$0.46, revenue of $3.92M](https://longbridge.com/en/news/296072173.md) - [Diamondback Energy Stock Outlook: Is Wall Street Bullish or Bearish?](https://longbridge.com/en/news/295769190.md) - [Persistent Asset Partners Ltd Purchases New Holdings in Equinox Gold Corp. $EQX](https://longbridge.com/en/news/296092473.md) - [Diamondback Energy EVP, Chief Legal, Admin Off Sold Shares Worth Over $506K](https://longbridge.com/en/news/296141689.md) - [FANG: Q2 2026 saw record production, strong earnings, and expanded capital returns amid higher guidance](https://longbridge.com/en/news/294762245.md)